Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! By
Tumor-Infiltrating Cd8+ Lymphocytes Effect on Clinical Outcome of Muco-Cutaneous Melanoma Publisher



Rahbar M1 ; Naraghi ZS2 ; Mardanpour M3 ; Mardanpour N4
Authors

Source: Indian Journal of Dermatology Published:2015


Abstract

Background: Recent data have changed our views of prognostic factors in cutaneous melanoma, while some newer methods have yielded better prognostic information. Tumor-infiltrating lymphocytes are believed to represent the immune reaction/response to melanoma cells which is often found in melanocytic cancer. Aim and Objective: We carried out an analysis, aiming to establish pooled estimates for clinical outcomes based on the presence of CD8+ T cell in melanocytic cancer. Materials and Methods: We have included 42 patients with primary cutaneous melanocytic cancer without preoperative treatments in our study. We next analyzed the proliferative activity of CD8+ T cells that infiltrated in tumor cell nests. The intratumoral and adjacent to invasive margin of tumor CD+ T-cell infiltration were analyzed which could also reflect antitumor immunity. Results: The total number of CD8+ cells especially adjacent to invasive margin of tumor was positively correlated with anatomical tumor thickness (P <.001) and not correlated with patient's age and sex. The stage of tumor which is related to vascular-neural invasion, regional lymph nodes involvement and tumor thickness shows positive correlation with CD8+ infiltration in tumor (P <.004, P <.005, P <.001), respectively. Acral melanoma shows more CD8 lymphocytes infiltration and also recurrence rate of tumor (P <.005). Conclusion: We believe that CD8+ T-cell infiltration in primary cutaneous melanocytic cancer represents the immune reaction/response to melanoma which could be an important new therapy for melanoma although more research is needed on this treatment modality. © 2015, Medical Knowledge. All rights reserved.
Other Related Docs
6. The Roles of Cd4+ T-Cells in Tumor Immunity, Cancer Immunology: A Translational Medicine Context# Second Edition (2020)
8. Cancer Immunology, Encyclopedia of Infection and Immunity (2022)
10. Cancer Immunology, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)
11. Chimeric Antigen Receptor T-Cell Therapy for Melanoma, Expert Review of Clinical Immunology (2021)
13. Differential Gene Expression and Tumorigenicity Analysis of Cultured Melanocyte Comparing Melanoma, International Journal of Molecular and Cellular Medicine (2024)
17. Biomarkers for Predicting the Outcome of Various Cancer Immunotherapies, Critical Reviews in Oncology/Hematology (2021)
19. The Role of T Helper 17 and Regulatory T Cells in Tumor Microenvironment, Immunopharmacology and Immunotoxicology (2019)
20. The Role of Peptide-Based Tumor Vaccines on Cytokines of Adaptive Immunity: A Review, International Journal of Peptide Research and Therapeutics (2021)